Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UK.

Trial Profile

Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UK.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Apr 2014

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Mundipharma International
  • Most Recent Events

    • 13 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 12 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 25 Oct 2012 Planned end date changed from 1 Sep 2011 to 1 Nov 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top